INSIGHTS ON QUALITY CONTROL

• Practical Solutions For Protein Analytics And Residual DNA Testing

  Discover practical solutions for common quality control bottlenecks in biotherapy manufacturing. Learn how to improve protein analytics and DNA testing robustness and accelerate time to market.

• Material Transfer Into A Cleanroom: How To Reduce Contamination Risk At Every Step

  Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.

• Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

  Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

• Understanding cGMPs For Phase 1 Investigational Drugs

  Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.

• Accelerate Biologics Product Release With Seamless Viral Testing

  6/23/2025

  Explore viral safety testing for biologics, focusing on prevention, detection, and removal strategies, updated regulatory guidance, and common challenges in unprocessed bulk testing.

• The Analytical Advantage Across The Development Lifecycle

  5/7/2026

  Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.

• The Essential Ingredient For GxP Training Innovation

  6/4/2026

  Advanced learning tools depend entirely on the health of the underlying training matrix. Establish a clean, data-driven framework to reduce compliance risks and recover lost operational hours.

• ICH Q9 Revision 1: Enhancing Quality Risk Management

  8/12/2024

  ICH Q9 Revision 1 advances the framework of Quality Risk Management (QRM) in the pharmaceutical industry, by addressing technological advancements and evolving regulatory expectations.

• Lentiviral Vector Upstream Process

  12/12/2025

  Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.